BACK TO ALL STUDIES

Fort Bragg, NC: SARS_CoV-2 (COVID-19) United STATES Army Special Operations Command (USASOC) Active Duty Seroepidemiological Study

PRIMARY OBJECTIVE(s)

1) To improve our understanding of COVID-19 transmission in a training environment, including source of the virus, how the virus may have spread so rapidly, and the role of symptomatic/asymptomatic transmission. 2) To improve our understanding of the development of immunity to SARS-CoV-2.

PRINCIPAL INVESTIGATOR(S)

Sammy Choi

CONTACT
Sammy Choi
young.s.choi.civ@mail.mil
TREATMENT/CLINICAL & LAB INVESTIGATION

No treatment. SARS-CoV-2 antibody and neutralizing antibody testing.

POPULATION
USASOC individuals
FULL NAME OF DIAGNOSTIC TEST
Lab Used for Diagnostic Test
Full Name of Serology/Antibody Test

Roche Elecsys Anti-SARS-CoV-2 assay on the Roche Cobas e System of IgG and IgM; neutralizing antibodies to be conducted via standard Virus Neutralization Test or high sensitivity and specificity commercial Surrogate Virus Neutralization Test

Lab Used for Serology/Antibody Test
Womack Army Medical Center, Fort Bragg, NC
Want more information about this study?
study website